|
Immunotherapy
Citations 181-190 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Induction of tumor NK-cell immunity by anti-CD69 antibody therapy
- Enric Esplugues, Javier Vega-Ramos, David Cartoixà, Berta N. Vazquez, Ignasi Salaet, Pablo Engel, and Pilar Lauzurica
Blood 2005; 105: 4399-4406.
[Abstract]
[Full text]
[PDF]
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy
- Peng H. Tan, Sven C. Beutelspacher, Shao-An Xue, Yao-He Wang, Peter Mitchell, James C. McAlister, D. Frank P. Larkin, Myra O. McClure, Hans J. Stauss, Mary A. Ritter, Giovanna Lombardi, and Andrew J. T. George
Blood 2005; 105: 3824-3832.
[Abstract]
[Full text]
[PDF]
NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
- Frits van Rhee, Susann M. Szmania, Fenghuang Zhan, Sushil K. Gupta, Mindy Pomtree, Pei Lin, Ramesh B. Batchu, Amberly Moreno, Guilio Spagnoli, John Shaughnessy, and Guido Tricot
Blood 2005; 105: 3939-3944.
[Abstract]
[Full text]
[PDF]
Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells
- Young-Ran Lee, In-Ho Yang, Young-Hee Lee, Sun-A Im, Sukgil Song, Hong Li, Kun Han, Kyungjae Kim, Seong Kug Eo, and Chong-Kil Lee
Blood 2005; 105: 3951-3955.
[Abstract]
[Full text]
[PDF]
An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma
- Stephen D. Gillies, Yan Lan, Steven Williams, Frank Carr, Stephen Forman, Andrew Raubitschek, and Kin-Ming Lo
Blood 2005; 105: 3972-3978.
[Abstract]
[Full text]
[PDF]
Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma
- Jun Okamura, Atae Utsunomiya, Ryuji Tanosaki, Naokuni Uike, Shunro Sonoda, Mari Kannagi, Masao Tomonaga, Mine Harada, Nobuhiro Kimura, Masato Masuda, Fumio Kawano, Yuji Yufu, Hiroyoshi Hattori, Hiroshi Kikuchi, and Yoshio Saburi
Blood 2005; 105: 4143-4145.
[Abstract]
[Full text]
[PDF]
Dendritic-cell activation by secretory phospholipase A2
- Reinhold Ramoner, Thomas Putz, Hubert Gander, Andrea Rahm, Georg Bartsch, Claudia Schaber, and Martin Thurnher
Blood 2005; 105: 3583-3587.
[Abstract]
[Full text]
[PDF]
Reversal of long-term sepsis-induced immunosuppression by dendritic cells
- Claudia F. Benjamim, Steven K. Lundy, Nicholas W. Lukacs, Cory M. Hogaboam, and Steven L. Kunkel
Blood 2005; 105: 3588-3595.
[Abstract]
[Full text]
[PDF]
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responses
- Sara Muraro, Attilio Bondanza, Matteo Bellone, Philip D. Greenberg, and Chiara Bonini
Blood 2005; 105: 3596-3604.
[Abstract]
[Full text]
[PDF]
Hodgkin lymphoma therapy with interleukin-4 receptor–directed cytotoxin in an infiltrating animal model
- Mariko Kawakami, Koji Kawakami, Mitomu Kioi, Pamela Leland, and Raj K. Puri
Blood 2005; 105: 3707-3713.
[Abstract]
[Full text]
[PDF]
|
|
